These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 15464104

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Role of cytochrome P450 2A6 polymorphism in nicotine metabolism and tobacco-dependent behaviour].
    Xia XY, Peng RX.
    Yao Xue Xue Bao; 2004 Sep; 39(9):758-63. PubMed ID: 15606031
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metabolism and disposition kinetics of nicotine.
    Hukkanen J, Jacob P, Benowitz NL.
    Pharmacol Rev; 2005 Mar; 57(1):79-115. PubMed ID: 15734728
    [Abstract] [Full Text] [Related]

  • 7. Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism.
    von Weymarn LB, Brown KM, Murphy SE.
    J Pharmacol Exp Ther; 2006 Jan; 316(1):295-303. PubMed ID: 16188955
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans.
    Nakajima M, Yamagishi S, Yamamoto H, Yamamoto T, Kuroiwa Y, Yokoi T.
    Clin Pharmacol Ther; 2000 Jan; 67(1):57-69. PubMed ID: 10668854
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreasing smoking behaviour and risk through CYP2A6 inhibition.
    Sellers EM, Tyndale RF, Fernandes LC.
    Drug Discov Today; 2003 Jun 01; 8(11):487-93. PubMed ID: 12818518
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
    Sellers EM, Kaplan HL, Tyndale RF.
    Clin Pharmacol Ther; 2000 Jul 01; 68(1):35-43. PubMed ID: 10945314
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administration.
    Schoedel KA, Sellers EM, Palmour R, Tyndale RF.
    Mol Pharmacol; 2003 Jan 01; 63(1):96-104. PubMed ID: 12488541
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
    Ring HZ, Valdes AM, Nishita DM, Prasad S, Jacob P, Tyndale RF, Swan GE, Benowitz NL.
    Pharmacogenet Genomics; 2007 Dec 01; 17(12):1007-15. PubMed ID: 18004205
    [Abstract] [Full Text] [Related]

  • 18. CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ion.
    von Weymarn LB, Retzlaff C, Murphy SE.
    J Pharmacol Exp Ther; 2012 Nov 01; 343(2):307-15. PubMed ID: 22869927
    [Abstract] [Full Text] [Related]

  • 19. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T, Nakajima-Taniguchi C, Fukuda T, Funamoto M, Maeda M, Tange E, Ueki R, Kawashima K, Hara H, Fujio Y, Azuma J.
    Pharmacogenomics J; 2006 Nov 01; 6(2):115-9. PubMed ID: 16402086
    [Abstract] [Full Text] [Related]

  • 20. Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted.
    Yamanaka H, Nakajima M, Nishimura K, Yoshida R, Fukami T, Katoh M, Yokoi T.
    Eur J Pharm Sci; 2004 Aug 01; 22(5):419-25. PubMed ID: 15265511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.